Law360 (subscription)

Law360 (subscription)
Share

Law360 (subscription)

 •  November 22

Law360, New York (November 21, 2017, 7:54 PM EST) -- The U.S. Food and Drug Administration voiced concerns about promotions for an insomnia spray that left out risk information, scolded an online retailer of disposable cigarette filters for making unapproved claims, and upbraided a nutritional supplement maker for labeling claims and other...

Law360 (subscription)

 •  October 21

Law360, San Jose (October 20, 2017, 11:25 PM EDT) -- German drugmaker Boehringer Ingelheim Pharmaceuticals Inc. filed a pair of patent infringement suits Friday in New Jersey federal court over bids by Sandoz Inc. and Sun Pharmaceutical Industries to market generic versions of its cancer therapy drug. The suits seek from the court declaratory...

Law360 (subscription)

 •  October 13

Law360, Boston (October 13, 2017, 4:07 PM EDT) -- The United Kingdom’s antitrust watchdog has started investigating a South African pharmaceutical company over the supply of two drugs used to treat the effects of adrenal gland diseases, the drugmaker said Friday, continuing the enforcer’s focus on the pharmaceutical sector. The Competition and...

Law360 (subscription)

 •  September 25

Law360, New York (September 25, 2017, 6:44 PM EDT) -- A Pennsylvania federal court dismissed Monday a health plan’s potential class action accusing more than a dozen major drugmakers of fixing the prices of generic drugs, saying the plan couldn't have relied on the alleged misconduct of the drugmakers when deciding how much it owed providers based...

Law360 (subscription)

 •  August 31

Law360, New York (August 31, 2017, 4:56 PM EDT) -- The D.C. federal court has ordered generic-drug maker Mylan Pharmaceuticals and chemical companies Cambrex and Gyma Laboratories to pay a combined $67 million to Blue Cross Blue Shield of Massachusetts and three other insurers in a long-running suit accusing the three companies of violating state...

Law360 (subscription)

 •  August 23

Law360, Springfield (August 22, 2017, 9:16 PM EDT) -- Drugmaker AmerisourceBergen was hit with a proposed class action Monday alleging the company violates the Fair Labor Standards Act by not paying call center employees for the time it takes to boot up their computers and otherwise prepare for the day. The case is the latest in a spate of “wage...

Law360 (subscription)

 •  August 21

Law360, New York (August 21, 2017, 1:18 PM EDT) -- Endo International PLC misrepresented the safety of its opioid Opana ER, ultimately causing the company to pull the drug from the market and the stock price to plunge, according to a proposed class action filed in Pennsylvania federal court. Shareholder Brandon Bier on Thursday said that a...

Law360, New York (July 5, 2017, 5:03 PM EDT) -- Big-name generic-drug makers performed shabby testing of finished medicines, a Chinese laboratory refused to hand over records to inspectors, and a popular pet food contained a powerful anesthetic that possibly killed a dog, according to newly released U.S. Food and Drug Administration records. Dr....

Law360, New York (July 3, 2017, 6:28 PM EDT) -- A coalition of painkiller-focused drugmakers on Monday urged the U.S. Food and Drug Administration to phase out prescription opioids that lack abuse-deterrent properties after the agency approves three anti-abuse versions. In a citizen petition, the Center for Lawful Access and Abuse Deterrence called...

Law360, New York (May 18, 2017, 5:13 PM EDT) -- A pharmacy benefit manager that agreed to purchase products from a dermatological drugmaker repeatedly overcharged the pharmaceutical company for certain related services, according to a complaint filed Wednesday in Pennsylvania federal court. Aqua Pharmaceuticals LLC said an audit in 2016 and 2017 of...